T1DX-QI Learning Sessions: Promoting Health Equity in T1D Care
On November 8th and 9th 2021 the T1D Exchange Quality Improvement Collaborative (T1DX-QI) held another semi-annual learning session. Held virtually,…
Get Up Close and in the Know with Sean Salmon, President of Medtronic Diabetes
T1D Exchange recently had the opportunity to interview Sean Salmon, President of Medtronic Diabetes. In this interview, we discuss Medtronic’s…
New Consensus Report from ADA and EASD on the Management of T1D in Adults, Summarized
A new consensus report, The Management of Type 1 Diabetes in Adults, was recently published.1,2 The report, crafted by 14…
Status Update: Connected Insulin Delivery Devices
Do these stats surprise you? Of the 1.6 million people with type 1 diabetes in the US,1 only 30 to…
Status Update: Automated Insulin Delivery Devices
The holy grail of insulin delivery for people with diabetes who use insulin is automated insulin delivery (AID) (current term…
Latest News on CGM and Dexcom Straight from the CEO, Kevin Sayer
T1D Exchange recently took advantage of the golden opportunity to interview Kevin Sayer, chairman, president and CEO of Dexcom. In…
A Look Inside the FDA’s Review Processes for Medical Devices
Learn the difference between the terms FDA-cleared and FDA- approved Understand the categories and pathway for FDA review for Class…
Bigfoot Unity Cleared and Ready to Step Out: Interview with Jeffrey Brewer, CEO, Bigfoot Biomedical
On May 10, 2021 Bigfoot Biomedical Inc. received FDA Clearance for its Bigfoot Unity Diabetes Management System. Jeffrey Brewer is…
How the T1D Exchange Quality Improvement Collaborative Applies ‘Big Data’ to Improve Diabetes Care
Get a glimpse in this interview with Nudrat Noor, on how the T1D Exchange Quality Improvement Collaborative (QIC) is gathering…
